Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: A Phase I/Iia Clinical Study

Molecular Therapy - United States
doi 10.1038/mt.2013.155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Oculopharyngeal Muscular Dystrophy

2020English

Oculopharyngeal Muscular Dystrophy in Italy

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
1997English

Guanabenz Treatment Improves Oculopharyngeal Muscular Dystrophy Phenotype

2018English

Functional Impact of an Oculopharyngeal Muscular Dystrophy Mutation in PABPN1

Journal of Physiology
PhysiologySports Science
2017English

hnRNP A1 and a/B Interaction With PABPN1 in Oculopharyngeal Muscular Dystrophy

Canadian Journal of Neurological Sciences
MedicineNeurology
2003English

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Phase IIa Cross-Over Study of Propylene Glycol-Free Melphalan (LGD-353) and Alkeran in Multiple Myeloma Autologous Transplantation

Bone Marrow Transplantation
TransplantationHematology
2014English

Lithium Chloride Attenuates Cell Death in Oculopharyngeal Muscular Dystrophy by Perturbing WNT/Β-Catenin Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial

Cell Transplantation
TransplantationBiomedical EngineeringCell Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy